Ubie key facts
as of Oct 2026- Operator of a global health-tech platform intended to provide artificial intelligence(AI) disease prediction and SaaS products.
- Ubie is valued at approximately $216.3M as of Oct 2026 (last reported valuation).
- It has raised $228.9M; the latest was Later Stage VC ($125.0M) in Jun 2025.
- Notable investors include Google for Startups, SBI Investment, J-Startup, Alphabet, Japan Finance Corporation — 30 tracked in total.
- Status: Privately Held (backing).
Ubie's last reported valuation, Apr 2024. Nothing priced has surfaced since.
- ·The complete investor list: 30 names
- ·Watch Ubie: the Monday email on marks, rounds and moves
Ubie funding rounds
No funding rounds for Ubie are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Ubie
30+Ubie valuation
Ubie's last reported valuation was $216 million in Apr 2024. No priced round, secondary trade or fund mark has surfaced since.
Ubie investors
30 investors are on record for Ubie, including Google for Startups, SBI Investment, J-Startup and Alphabet.
About Ubie
Operator of a global health-tech platform intended to provide artificial intelligence(AI) disease prediction and SaaS products. The company's disease prediction AI determines potential conditions and the next best steps in a patient's care journey based on symptoms and medical history by leveraging technology, enabling healthcare providers to reduce doctor's desk work and patient wait time with solutions designed to improve efficiency and care coordination.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2015
- Employees
- 220
- Website
- ubie.life/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.